🔗 Share this article

Treasury head Reeves has revealed she is planning "targeted steps to address cost of living issues" in the forthcoming financial statement.

Speaking to media outlets, she emphasized that curbing price rises is a collective duty of both the government and the central bank.

The United Kingdom's inflation rate is expected to be the most elevated among the Group of Seven advanced economies this calendar year and the following year.

Potential Utility Bill Measures

Reports indicate the administration could take action to reduce energy bills, for example by reducing the current 5% level of value-added tax charged on energy supplies.

Another approach is to cut some of the government charges presently added to household expenses.

Budgetary Constraints and Expert Predictions

The administration will obtain the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much scope there is for these measures.

The expectation from most experts is that the Chancellor will have to declare tax increases or spending cuts in order to meet her self-imposed debt limits.

Earlier on Thursday, calculations indicated there was a £22bn deficit for the chancellor to fill, which is at the lower end of forecasts.

"There's a shared job between the Bank of England and the government to bear down further on some of the sources of inflation," the Chancellor told the BBC in Washington, at the yearly gatherings of the IMF and World Bank.

Revenue Commitments and International Concerns

While much of the attention has been on expected tax rises, the Treasury chief said the most recent information from the OBR had not altered her pledge to campaign commitments not to raise rates on income tax, VAT or National Insurance.

She attributed an "uncertain global environment" with growing geopolitical and trade tensions for the Budget tax moves, probably to be directed on those "wealthiest."

International Trade Tensions

Referring to apprehensions about the UK's commercial links with the Asian nation she said: "Our security interests always are paramount."

Recent statement by Chinese authorities to strengthen trade restrictions on rare earths and other resources that are essential for advanced tech manufacturing led American leader the US President to propose an additional 100% import tax on goods from China, increasing the possibility of an full-scale commercial conflict between the two global powers.

The American finance chief described the Chinese decision "commercial pressure" and "a global supply chain power grab."

Inquired about accepting the American proposal to participate in its battle with the Asian nation, Reeves said she was "extremely troubled" by China's actions and urged the Chinese government "not to put up barriers and restrict access."

She said the decision was "damaging for the global economy and generates further headwinds."

"I believe there are sectors where we need to address Chinese policies, but there are also valuable opportunities to sell into Chinese markets, including banking sector and other sectors of the economy. We've got to achieve that balance right."

The chancellor also affirmed she was cooperating with other major economies "regarding our own critical minerals plan, so that we are more independent."

NHS Drug Costs and Funding

The Chancellor also recognized that the price the National Health Service pays for medicines could increase as a result of ongoing talks with the US government and its drugs companies, in return for reduced taxes and investment.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or canceling operations in the UK, with several blaming the low prices they are receiving.

Recently, the Science Minister said the price the health service pays for medicines would have to rise to prevent companies and drug research funding departing from the United Kingdom.

Reeves informed the BBC: "It has been observed due to the payment system, that medical research, new drugs have not been offered in the UK in the extent that they are in other EU nations."

"We want to ensure that people receiving care from the NHS are can access the finest critical treatments in the world. And so we are looking at this situation, and... seeking to obtain more funding into Britain."